Universal Accessible Biomarkers of Drug-Induced Tissue Injury and Systemic Inflammation in Rat: Performance Assessment of TIMP-1, A2M, AGP, NGAL, and Albumin
The ability to monitor for general drug-induced tissue injury (DITI) or systemic inflammation in any tissue using blood-based accessible biomarkers would provide a valuable tool in early exploratory animal studies to understand potential drug liabilities. Here we describe the evaluation of 4 biomark...
Saved in:
Published in | Toxicological sciences Vol. 187; no. 2; pp. 219 - 233 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
26.05.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The ability to monitor for general drug-induced tissue injury (DITI) or systemic inflammation in any tissue using blood-based accessible biomarkers would provide a valuable tool in early exploratory animal studies to understand potential drug liabilities. Here we describe the evaluation of 4 biomarkers of tissue remodeling and inflammation (α2-macroglobulin [A2M], α1-acid glycoprotein [AGP], neutrophil gelatinase-associated lipocalin [NGAL], and tissue inhibitor of metalloproteinases [TIMP-1]) as well as the traditional serum parameter albumin as potential blood-based biomarkers of DITI and systemic inflammatory response (SIR). Biomarker performance was assessed in 51 short-term rat in vivo studies with various end-organ toxicities or SIR and receiver operating characteristic curves were generated to compare relative performances. All 4 biomarkers performed well in their ability to detect DITI and SIR with an area under the curve (AUC) of 0.82-0.78, however TIMP-1 achieved the best sensitivity (at 95% specificity) of 61%; AGP, NGAL, and A2M sensitivity was 51%-52%. AUC for albumin was 0.72 with sensitivity of 39%. A2M was the best performer in studies with only SIR (AUC 0.91). In the subset of studies with drug-induced vascular injury, TIMP-1 performed best with an AUC of 0.96. Poor performance of all tested biomarkers was observed in samples with CNS toxicity. In summary, TIMP-1, A2M, AGP, and NGAL demonstrated performance as sensitive accessible biomarkers of DITI and SIR, supporting their potential application as universal accessible tissue toxicity biomarkers to quickly identify dose levels associated with drug-induced injury in early exploratory rat safety and other studies. |
---|---|
AbstractList | Abstract
The ability to monitor for general drug-induced tissue injury (DITI) or systemic inflammation in any tissue using blood-based accessible biomarkers would provide a valuable tool in early exploratory animal studies to understand potential drug liabilities. Here we describe the evaluation of 4 biomarkers of tissue remodeling and inflammation (α2-macroglobulin [A2M], α1-acid glycoprotein [AGP], neutrophil gelatinase-associated lipocalin [NGAL], and tissue inhibitor of metalloproteinases [TIMP-1]) as well as the traditional serum parameter albumin as potential blood-based biomarkers of DITI and systemic inflammatory response (SIR). Biomarker performance was assessed in 51 short-term rat in vivo studies with various end-organ toxicities or SIR and receiver operating characteristic curves were generated to compare relative performances. All 4 biomarkers performed well in their ability to detect DITI and SIR with an area under the curve (AUC) of 0.82–0.78, however TIMP-1 achieved the best sensitivity (at 95% specificity) of 61%; AGP, NGAL, and A2M sensitivity was 51%–52%. AUC for albumin was 0.72 with sensitivity of 39%. A2M was the best performer in studies with only SIR (AUC 0.91). In the subset of studies with drug-induced vascular injury, TIMP-1 performed best with an AUC of 0.96. Poor performance of all tested biomarkers was observed in samples with CNS toxicity. In summary, TIMP-1, A2M, AGP, and NGAL demonstrated performance as sensitive accessible biomarkers of DITI and SIR, supporting their potential application as universal accessible tissue toxicity biomarkers to quickly identify dose levels associated with drug-induced injury in early exploratory rat safety and other studies. The ability to monitor for general drug-induced tissue injury (DITI) or systemic inflammation in any tissue using blood-based accessible biomarkers would provide a valuable tool in early exploratory animal studies to understand potential drug liabilities. Here we describe the evaluation of 4 biomarkers of tissue remodeling and inflammation (α2-macroglobulin [A2M], α1-acid glycoprotein [AGP], neutrophil gelatinase-associated lipocalin [NGAL], and tissue inhibitor of metalloproteinases [TIMP-1]) as well as the traditional serum parameter albumin as potential blood-based biomarkers of DITI and systemic inflammatory response (SIR). Biomarker performance was assessed in 51 short-term rat in vivo studies with various end-organ toxicities or SIR and receiver operating characteristic curves were generated to compare relative performances. All 4 biomarkers performed well in their ability to detect DITI and SIR with an area under the curve (AUC) of 0.82-0.78, however TIMP-1 achieved the best sensitivity (at 95% specificity) of 61%; AGP, NGAL, and A2M sensitivity was 51%-52%. AUC for albumin was 0.72 with sensitivity of 39%. A2M was the best performer in studies with only SIR (AUC 0.91). In the subset of studies with drug-induced vascular injury, TIMP-1 performed best with an AUC of 0.96. Poor performance of all tested biomarkers was observed in samples with CNS toxicity. In summary, TIMP-1, A2M, AGP, and NGAL demonstrated performance as sensitive accessible biomarkers of DITI and SIR, supporting their potential application as universal accessible tissue toxicity biomarkers to quickly identify dose levels associated with drug-induced injury in early exploratory rat safety and other studies. |
Author | Glaab, Warren E Bourque, Jennifer Vlasakova, Katerina Gonzalez, Raymond J Patel, Shetal Bailey, Wendy J Besteman, Elizabeth G Sistare, Frank D |
Author_xml | – sequence: 1 givenname: Katerina surname: Vlasakova fullname: Vlasakova, Katerina organization: Merck & Co., Inc., Nonclinical Drug Safety, West Point, Pennsylvania 19486, USA – sequence: 2 givenname: Jennifer surname: Bourque fullname: Bourque, Jennifer organization: Merck & Co., Inc., Nonclinical Drug Safety, West Point, Pennsylvania 19486, USA – sequence: 3 givenname: Wendy J surname: Bailey fullname: Bailey, Wendy J organization: Merck & Co., Inc., Nonclinical Drug Safety, West Point, Pennsylvania 19486, USA – sequence: 4 givenname: Shetal surname: Patel fullname: Patel, Shetal organization: Merck & Co., Inc., Nonclinical Drug Safety, West Point, Pennsylvania 19486, USA – sequence: 5 givenname: Elizabeth G surname: Besteman fullname: Besteman, Elizabeth G organization: Merck & Co., Inc., Nonclinical Drug Safety, West Point, Pennsylvania 19486, USA – sequence: 6 givenname: Raymond J surname: Gonzalez fullname: Gonzalez, Raymond J organization: Merck & Co., Inc., Nonclinical Drug Safety, West Point, Pennsylvania 19486, USA – sequence: 7 givenname: Frank D surname: Sistare fullname: Sistare, Frank D organization: Merck & Co., Inc., Nonclinical Drug Safety, West Point, Pennsylvania 19486, USA – sequence: 8 givenname: Warren E surname: Glaab fullname: Glaab, Warren E organization: Merck & Co., Inc., Nonclinical Drug Safety, West Point, Pennsylvania 19486, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35285504$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kU1v1DAQhi1URD_gyhH5yGHT-iPZxNxCgWWlLaxge44cZ4zcxnbrSRD7Y_ivuOzCZWb06p1npHnPyUmIAQh5zdklZ0peTfEXGnd1b7Vhkj0jZ1ldFkwJdXKcl6xhp-Qc8Y4xzpdMvSCnshJNVbHyjPy-De4nJNQjbY0BRNePQN-76HW6zzqNln5I849iHYbZwEB3DnEGug53c9pTHQb6fY8TeGeyZkftvZ5cDNQF-k1P7-gWko3J62CAtoj5gocwPWF365ttwRe0FTe5rLYL-mXVbhZ_me3Yz96Fl-S51SPCq2O_ILefPu6uPxebr6v1dbspjFDVVAjTWFPXSjayFwIGWVZ1paqhasAaU2uAHuTApOmZWMralJyBKo2tRcl1X5fygrw9cB9SfJwBp847NDCOOkCcsctbjSp52YhsvTxYTYqICWz3kFx-1r7jrHuKpDtE0h0jyQtvjuy59zD8t__LQP4BS66LXA |
CitedBy_id | crossref_primary_10_3389_fimmu_2023_1310271 crossref_primary_10_1016_j_vacune_2024_05_002 crossref_primary_10_1097_MCC_0000000000001089 crossref_primary_10_1016_j_vacun_2024_01_001 crossref_primary_10_3389_fped_2022_947059 |
Cites_doi | 10.1016/0009-8981(71)90365-2 10.1016/j.tem.2017.01.003 10.1002/jpen.1451 10.1016/j.tcb.2018.08.006 10.1186/s12931-016-0379-7 10.1093/toxsci/kfab038 10.1046/j.1523-1755.1998.00734.x 10.1177/0192623317720731 10.1186/2045-3701-1-14 10.2147/IJGM.S102819 10.1016/0005-2795(81)90033-7 10.3109/1354750X.2015.1123354 10.1093/toxsci/kfs243 10.1186/1471-2369-13-25 10.1016/S1359-6101(02)00054-0 10.1136/jcp.2008.061010 10.1093/toxsci/58.1.195 10.1177/0192623320957281 10.1258/la.2009.009042 10.1093/toxsci/kft330 10.1155/2016/9085273 10.1042/bj1720129 10.1093/toxsci/kfm161 10.1097/SHK.0b013e31823918c2 10.1007/s11095-018-2551-x 10.1093/clinchem/11.4.478 10.1186/s42826-019-0014-0 10.1046/j.1435-6935.2002.00025.x |
ContentType | Journal Article |
Copyright | The Author(s) 2022. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
Copyright_xml | – notice: The Author(s) 2022. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1093/toxsci/kfac030 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1096-0929 |
EndPage | 233 |
ExternalDocumentID | 10_1093_toxsci_kfac030 35285504 |
Genre | Journal Article |
GroupedDBID | --- -E4 .2P .I3 .ZR 0R~ 123 18M 1TH 1~5 29Q 2WC 4.4 48X 4G. 53G 5RE 5VS 5WA 5WD 7-5 70D A8Z AABZA AACTN AACZT AAHBH AAIMJ AAJKP AAMDB AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AASNB AAUAY AAVAP AAVLN ABEUO ABIXL ABJNI ABKDP ABMNT ABNHQ ABNKS ABPTD ABQLI ABWST ABXVV ABZBJ ACGFO ACGFS ACUFI ACUTJ ACUTO ADBBV ADEYI ADEZT ADGKP ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZTZ ADZXQ AEGPL AEGXH AEJOX AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFGWE AFIYH AFOFC AFXEN AGINJ AGKEF AGQXC AGSYK AHXPO AIJHB AJEEA AKHUL AKRWK AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APWMN ARIXL ATGXG AXUDD AYOIW BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BSWAC BTRTY BVRKM CDBKE CGR CS3 CUY CVF CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS ECM EDH EE~ EIF EMOBN ESTFP F5P F9B FDB FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HH5 HW0 HZ~ I-F IOX J21 KAQDR KOP KQ8 KSI KSN M-Z M49 N9A NGC NLBLG NOMLY NOYVH NPM NQ- NU- O-L O9- OAWHX OBOKY OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OWPYF P2P PAFKI PEELM Q1. Q5Y R44 RD5 ROL ROX RUSNO RW1 RXO SV3 TJX TLC TR2 W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ~02 ~91 AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c295t-2c8fc779383b22ed3457595d58efcc7aeebe3d03cb02637c410e94cf7241ab743 |
ISSN | 1096-6080 |
IngestDate | Fri Aug 16 21:21:16 EDT 2024 Fri Aug 23 00:38:40 EDT 2024 Tue Aug 27 13:49:57 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | α1-acid glycoprotein α2-macroglobulin rat neutrophil gelatinase-associated lipocalin tissue inhibitor of metalloproteinases albumin drug-induced tissue injury |
Language | English |
License | The Author(s) 2022. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c295t-2c8fc779383b22ed3457595d58efcc7aeebe3d03cb02637c410e94cf7241ab743 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 35285504 |
PQID | 2638941482 |
PQPubID | 23479 |
PageCount | 15 |
ParticipantIDs | proquest_miscellaneous_2638941482 crossref_primary_10_1093_toxsci_kfac030 pubmed_primary_35285504 |
PublicationCentury | 2000 |
PublicationDate | 2022-05-26 |
PublicationDateYYYYMMDD | 2022-05-26 |
PublicationDate_xml | – month: 05 year: 2022 text: 2022-05-26 day: 26 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Toxicological sciences |
PublicationTitleAlternate | Toxicol Sci |
PublicationYear | 2022 |
References | Cray (2022053118094969100_kfac030-B7) 2009; 59 Zaias (2022053118094969100_kfac030-B35) 2009; 48 Wang (2022053118094969100_kfac030-B34) 2011; 1 Stevenson (2022053118094969100_kfac030-B31) 1998; 53 Gonzalez (2022053118094969100_kfac030-B11) 2017; 45 Han (2022053118094969100_kfac030-B13) 2012; 13 Dagues (2022053118094969100_kfac030-B8) 2007; 100 Hochepied (2022053118094969100_kfac030-B15) 2003; 14 Honjo (2022053118094969100_kfac030-B16) 2010; 44 Bailey (2022053118094969100_kfac030-B3) 2012; 130 Abella (2022053118094969100_kfac030-B1) 2015; 20 Hubert (2022053118094969100_kfac030-B17) 2000; 58 Rodkey (2022053118094969100_kfac030-B26) 1965; 11 Rose (2022053118094969100_kfac030-B27) 2015; 54 Grunwald (2022053118094969100_kfac030-B12) 2019; 29 Okubo (2022053118094969100_kfac030-B23) 1981; 668 Soeters (2022053118094969100_kfac030-B29) 2019; 43 Ayala (2022053118094969100_kfac030-B2) 2016; 17 Chua (2022053118094969100_kfac030-B6) 2003; 10 Ito (2022053118094969100_kfac030-B18) 2019; 35 Soreide (2022053118094969100_kfac030-B30) 2009; 62 Sultan (2022053118094969100_kfac030-B32) 2012; 37 Pain (2022053118094969100_kfac030-B24) 1978; 172 Reagan (2022053118094969100_kfac030-B25) 2020; 48 Haschek (2022053118094969100_kfac030-B14) 2013 Mazzaferro (2022053118094969100_kfac030-B21) 2002; 12 Vlasakova (2022053118094969100_kfac030-B33) 2014; 138 Biesmans (2022053118094969100_kfac030-B4) 2016; 2016 Smith (2022053118094969100_kfac030-B28) 2018; 36 Chakraborty (2022053118094969100_kfac030-B5) 2012; 1826 Latimer (2022053118094969100_kfac030-B19) 2011 Doumas (2022053118094969100_kfac030-B9) 1971; 31 Glaab (2022053118094969100_kfac030-B10) 2021 Moschen (2022053118094969100_kfac030-B22) 2017; 28 Levitt (2022053118094969100_kfac030-B20) 2016; 9 |
References_xml | – volume: 10 start-page: 308 year: 2003 ident: 2022053118094969100_kfac030-B6 article-title: Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease publication-title: Clin. Diagn. Lab. Immunol contributor: fullname: Chua – volume: 31 start-page: 87 year: 1971 ident: 2022053118094969100_kfac030-B9 article-title: Albumin standards and the measurement of serum albumin with bromcresol green publication-title: Clin. Chim. Acta doi: 10.1016/0009-8981(71)90365-2 contributor: fullname: Doumas – volume: 54 start-page: 459 year: 2015 ident: 2022053118094969100_kfac030-B27 article-title: Relationship between plasma albumin concentration and plasma volume in 5 inbred rat strains publication-title: J. Am. Assoc. Lab. Anim. Sci contributor: fullname: Rose – volume: 28 start-page: 388 year: 2017 ident: 2022053118094969100_kfac030-B22 article-title: Lipocalin-2: A master mediator of intestinal and metabolic inflammation publication-title: Trends Endocrinol. Metab doi: 10.1016/j.tem.2017.01.003 contributor: fullname: Moschen – volume: 43 start-page: 181 year: 2019 ident: 2022053118094969100_kfac030-B29 article-title: Hypoalbuminemia: Pathogenesis and clinical significance publication-title: JPEN J. Parenter. Enteral. Nutr doi: 10.1002/jpen.1451 contributor: fullname: Soeters – volume: 29 start-page: 6 year: 2019 ident: 2022053118094969100_kfac030-B12 article-title: Recognizing the molecular multifunctionality and interactome of TIMP-1 publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2018.08.006 contributor: fullname: Grunwald – volume: 17 start-page: 71 year: 2016 ident: 2022053118094969100_kfac030-B2 article-title: Acute lung injury induced by whole gastric fluid: Hepatic acute phase response contributes to increase lung antiprotease protection publication-title: Respir. Res doi: 10.1186/s12931-016-0379-7 contributor: fullname: Ayala – start-page: 148 year: 2021 ident: 2022053118094969100_kfac030-B10 article-title: Universal toxicity gene signatures for early identification of drug-induced tissue injuries in rats publication-title: Toxicol. Sci doi: 10.1093/toxsci/kfab038 contributor: fullname: Glaab – volume: 53 start-page: 67 year: 1998 ident: 2022053118094969100_kfac030-B31 article-title: Serum alpha 2-macroglobulin and alpha 1-inhibitor 3 concentrations are increased in hypoalbuminemia by post-transcriptional mechanisms publication-title: Kidney Int doi: 10.1046/j.1523-1755.1998.00734.x contributor: fullname: Stevenson – volume: 45 start-page: 633 year: 2017 ident: 2022053118094969100_kfac030-B11 article-title: Vascular imaging of matrix metalloproteinase activity as an informative preclinical biomarker of drug-induced vascular injury publication-title: Toxicol. Pathol doi: 10.1177/0192623317720731 contributor: fullname: Gonzalez – start-page: 573 volume-title: Haschek and Rousseaux’s Handbook of Toxicologic Pathology year: 2013 ident: 2022053118094969100_kfac030-B14 contributor: fullname: Haschek – volume: 1 start-page: 14 year: 2011 ident: 2022053118094969100_kfac030-B34 article-title: Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: Involvement of hepatocyte STAT3 in TIMP-1 production publication-title: Cell Biosci doi: 10.1186/2045-3701-1-14 contributor: fullname: Wang – volume: 9 start-page: 229 year: 2016 ident: 2022053118094969100_kfac030-B20 article-title: Human serum albumin homeostasis: A new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements publication-title: Int. J. Gen. Med doi: 10.2147/IJGM.S102819 contributor: fullname: Levitt – volume: 668 start-page: 257 year: 1981 ident: 2022053118094969100_kfac030-B23 article-title: Purification and immunological determination of A2-macroglobulin in serum from injured rats publication-title: Biochim. Biophys. Acta doi: 10.1016/0005-2795(81)90033-7 contributor: fullname: Okubo – volume: 20 start-page: 565 year: 2015 ident: 2022053118094969100_kfac030-B1 article-title: The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases publication-title: Biomarkers doi: 10.3109/1354750X.2015.1123354 contributor: fullname: Abella – volume: 130 start-page: 229 year: 2012 ident: 2022053118094969100_kfac030-B3 article-title: A performance evaluation of three drug-induced liver injury biomarkers in the rat: Alpha-glutathione S-transferase, arginase 1, and 4-hydroxyphenyl-pyruvate dioxygenase publication-title: Toxicol. Sci doi: 10.1093/toxsci/kfs243 contributor: fullname: Bailey – volume: 13 start-page: 25 year: 2012 ident: 2022053118094969100_kfac030-B13 article-title: Renal neutrophil gelatinase associated lipocalin expression in lipopolysaccharide-induced acute kidney injury in the rat publication-title: BMC Nephrol doi: 10.1186/1471-2369-13-25 contributor: fullname: Han – volume: 14 start-page: 25 year: 2003 ident: 2022053118094969100_kfac030-B15 article-title: Alpha(1)-acid glycoprotein: An acute phase protein with inflammatory and immunomodulating properties publication-title: Cytokine Growth Factor Rev doi: 10.1016/S1359-6101(02)00054-0 contributor: fullname: Hochepied – volume: 62 start-page: 1 year: 2009 ident: 2022053118094969100_kfac030-B30 article-title: Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research publication-title: J. Clin. Pathol doi: 10.1136/jcp.2008.061010 contributor: fullname: Soreide – volume: 1826 start-page: 129 year: 2012 ident: 2022053118094969100_kfac030-B5 article-title: The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer publication-title: Biochim. Biophys. Acta contributor: fullname: Chakraborty – volume: 58 start-page: 195 year: 2000 ident: 2022053118094969100_kfac030-B17 article-title: The effects of diet, ad libitum feeding, and moderate and severe dietary restriction on body weight, survival, clinical pathology parameters, and cause of death in control Sprague-Dawley rats publication-title: Toxicol. Sci doi: 10.1093/toxsci/58.1.195 contributor: fullname: Hubert – volume: 48 start-page: 845 year: 2020 ident: 2022053118094969100_kfac030-B25 article-title: Evaluation of rat acute phase proteins as inflammatory biomarkers for vaccine nonclinical safety studies publication-title: Toxicol. Pathol doi: 10.1177/0192623320957281 contributor: fullname: Reagan – volume: 44 start-page: 150 year: 2010 ident: 2022053118094969100_kfac030-B16 article-title: Kinetics of {alpha}2-macroglobulin and {alpha}1-acid glycoprotein in rats subjected to repeated acute inflammatory stimulation publication-title: Lab. Anim doi: 10.1258/la.2009.009042 contributor: fullname: Honjo – volume: 138 start-page: 3 year: 2014 ident: 2022053118094969100_kfac030-B33 article-title: Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies publication-title: Toxicol. Sci doi: 10.1093/toxsci/kft330 contributor: fullname: Vlasakova – volume: 48 start-page: 387 year: 2009 ident: 2022053118094969100_kfac030-B35 article-title: Reference values for serum proteins of common laboratory rodent strains publication-title: J. Am. Assoc. Lab. Anim. Sci contributor: fullname: Zaias – volume: 2016 start-page: 9085273 year: 2016 ident: 2022053118094969100_kfac030-B4 article-title: Systematic analysis of the cytokine and anhedonia response to peripheral lipopolysaccharide administration in rats publication-title: Biomed. Res. Int doi: 10.1155/2016/9085273 contributor: fullname: Biesmans – volume: 172 start-page: 129 year: 1978 ident: 2022053118094969100_kfac030-B24 article-title: The effect of dietary protein deficiency on albumin synthesis and on the concentration of active albumin messenger ribonucleic acid in rat liver publication-title: Biochem. J doi: 10.1042/bj1720129 contributor: fullname: Pain – volume: 100 start-page: 238 year: 2007 ident: 2022053118094969100_kfac030-B8 article-title: Investigation of the molecular mechanisms preceding PDE4 inhibitor-induced vasculopathy in rats: Tissue inhibitor of metalloproteinase 1, a potential predictive biomarker publication-title: Toxicol. Sci doi: 10.1093/toxsci/kfm161 contributor: fullname: Dagues – volume: 37 start-page: 191 year: 2012 ident: 2022053118094969100_kfac030-B32 article-title: LIPOCALIN-2 is a major acute-phase protein in a rat and mouse model of sterile abscess publication-title: Shock doi: 10.1097/SHK.0b013e31823918c2 contributor: fullname: Sultan – volume: 36 start-page: 30 year: 2018 ident: 2022053118094969100_kfac030-B28 article-title: Pharmacokinetic and pharmacodynamic considerations for drugs binding to alpha-1-acid glycoprotein publication-title: Pharm. Res doi: 10.1007/s11095-018-2551-x contributor: fullname: Smith – volume: 59 start-page: 517 year: 2009 ident: 2022053118094969100_kfac030-B7 article-title: Acute phase response in animals: A review publication-title: Comp. Med contributor: fullname: Cray – volume: 11 start-page: 478 year: 1965 ident: 2022053118094969100_kfac030-B26 article-title: Direct spectrophotometric determination of albumin in human serum publication-title: Clin. Chem doi: 10.1093/clinchem/11.4.478 contributor: fullname: Rodkey – volume: 35 start-page: 14 year: 2019 ident: 2022053118094969100_kfac030-B18 article-title: Correlation between synthesis of alpha2-macroglobulin as acute phase protein and degree of hepatopathy in rats publication-title: Lab. Anim. Res doi: 10.1186/s42826-019-0014-0 contributor: fullname: Ito – start-page: 177 volume-title: Duncan & Prasse’s Veterinary Laboratory Medicine: Clinical Pathology year: 2011 ident: 2022053118094969100_kfac030-B19 contributor: fullname: Latimer – volume: 12 start-page: 113 year: 2002 ident: 2022053118094969100_kfac030-B21 article-title: The role of albumin replacement in the critically ill veterinary patient publication-title: J. Vet. Emerg. Crit. Care doi: 10.1046/j.1435-6935.2002.00025.x contributor: fullname: Mazzaferro |
SSID | ssj0011609 |
Score | 2.438949 |
Snippet | The ability to monitor for general drug-induced tissue injury (DITI) or systemic inflammation in any tissue using blood-based accessible biomarkers would... Abstract The ability to monitor for general drug-induced tissue injury (DITI) or systemic inflammation in any tissue using blood-based accessible biomarkers... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 219 |
SubjectTerms | Acute Kidney Injury Albumins Animals Biomarkers Female Inflammation Lipocalin-2 Pregnancy Pregnancy-Associated alpha 2-Macroglobulins Rats ROC Curve Tissue Inhibitor of Metalloproteinase-1 |
Title | Universal Accessible Biomarkers of Drug-Induced Tissue Injury and Systemic Inflammation in Rat: Performance Assessment of TIMP-1, A2M, AGP, NGAL, and Albumin |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35285504 https://search.proquest.com/docview/2638941482 |
Volume | 187 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bjtMwELXKIiEkhKDcyk1GQstLs-vYufJWbl0QRRFkYd-ixHEgrEjQboq2_Aufxr8wvtTJQpEWXpLIUqaK53RmPJ45RughK4OQQKDseHFVOB4PZbMyj50idyWBvs88le9YvAn29r1XB_7BaPRzULW07Iod_n1jX8n_aBXGQK-yS_YfNGuFwgA8g37hChqG65l0bKoq5Cyrcw9r2Qb1pG6_yJqbI1Wk8exo-dGR53PIff5UzTLYhM8wk7poUxE51xzGKsCG7mOUOZC3ucoZJoO-gpkl8ZSC05eLxHGVaaELdZsnClrz2et1SajK_xtqbxMAp-1Jza3BNf7XxvXvIZbPD9tvpk9N8kg3fcYApgS82LAmp8_D1ib3_kE05arf60pAhkpyv_skOjOdJscBy2MiS-8GZhkWWk5A9JlPO6IfI7HJl1hbHg5ASzdYZu3kqWbf-MN_aG6trj2B74eHwyrnxOwbnaLq_s2F2sJGvaXPMi0hM--fQ-dpGPuh8ht2dea6gapAsh9nOUXZrn5_17x_Omb6y0JIBUTpFXTZrGTwTMPyKhqJZowuLEytxhhtJ5oVfTXFad_kdzzF2zjp-dJXY3RJp46x7oi7hn5YWOMe1riHNW4rPIQ11rDGGtYYgIfXsMZDWOO6wQDrx3gAatyDWorVoJ5igDRc5skUSzhPlUwD5uto_8Xz9OmeY04RcTiN_c6hPKp4CG4oYgWlomSePJPWL_1IVJyHuQAzxkrCeEFowELuuUTEHq9CiG3zAgLsG2iraRtxC2EWB0FUxFUVla7nFaQgIvI5466gJWOcT9CjtZ6yr5osJtuMiAl6sFZjBvZcbtLljWiXxxmVSwhPsvNO0E2tXytLMjH5PvFun_l37qCL_f_pLtrqjpbiHkTRXXFfYfEXQArLiA |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | ABC ChemistRy |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Universal+Accessible+Biomarkers+of+Drug-Induced+Tissue+Injury+and+Systemic+Inflammation+in+Rat%3A+Performance+Assessment+of+TIMP-1%2C+A2M%2C+AGP%2C+NGAL%2C+and+Albumin&rft.jtitle=Toxicological+sciences&rft.au=Vlasakova%2C+Katerina&rft.au=Bourque%2C+Jennifer&rft.au=Bailey%2C+Wendy+J&rft.au=Patel%2C+Shetal&rft.date=2022-05-26&rft.issn=1096-6080&rft.eissn=1096-0929&rft.volume=187&rft.issue=2&rft.spage=219&rft.epage=233&rft_id=info:doi/10.1093%2Ftoxsci%2Fkfac030&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_toxsci_kfac030 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1096-6080&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1096-6080&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1096-6080&client=summon |